Immunocore Holdings plc financial data

Symbol
IMCR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
90 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Immunocore Ltd (to 2/1/2021)
Latest financial report
Q1 2024 - May 8, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8 M shares +3.6%
Common Stock, Shares, Outstanding 50 M shares
Entity Public Float 2.7 B USD
Common Stock, Value, Issued 135 K USD
Weighted Average Number of Shares Outstanding, Basic 49.9 M shares +3.52%
Weighted Average Number of Shares Outstanding, Diluted 49.9 M shares +3.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 70.5 M USD +29%
Cost of Revenue 246 K USD +13.9%
Research and Development Expense 57.5 M USD +57.1%
Operating Income (Loss) -26.5 M USD -80.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.1 M USD -25.7%
Income Tax Expense (Benefit) 357 K USD +21.8%
Net Income (Loss) Attributable to Parent -24.4 M USD -25.6%
Earnings Per Share, Basic -0.49 USD/shares -22.5%
Earnings Per Share, Diluted -0.49 USD/shares -22.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 833 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 57.8 M USD
Inventory, Net 4.17 M USD
Other Assets, Current 9.71 M USD +168%
Assets, Current 926 M USD
Deferred Income Tax Assets, Net 10.8 M USD
Property, Plant and Equipment, Net 8.38 M USD
Operating Lease, Right-of-Use Asset 32.8 M USD
Other Assets, Noncurrent 16 M USD
Assets 994 M USD
Accounts Payable, Current 15.5 M USD
Employee-related Liabilities, Current 5.53 M USD
Liabilities, Current 155 M USD
Operating Lease, Liability, Noncurrent 34 M USD
Liabilities 634 M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -35.4 M USD
Retained Earnings (Accumulated Deficit) -769 M USD
Stockholders' Equity Attributable to Parent 360 M USD +5.34%
Liabilities and Equity 994 M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.59 M USD -144%
Net Cash Provided by (Used in) Financing Activities 396 M USD +6351%
Net Cash Provided by (Used in) Investing Activities -430 K USD +85.7%
Common Stock, Shares, Issued 50 M shares
Common Stock, Par or Stated Value Per Share 0 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 833 M USD +99.1%
Deferred Tax Assets, Valuation Allowance 83.1 M USD -3.83%
Deferred Tax Assets, Gross 95.3 M USD +3.09%
Operating Lease, Liability 35.2 M USD
Depreciation 1.01 M USD +6.2%
Payments to Acquire Property, Plant, and Equipment 430 K USD -85.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.5 M USD -95.9%
Lessee, Operating Lease, Liability, to be Paid 60.1 M USD
Property, Plant and Equipment, Gross 61.5 M USD +15%
Operating Lease, Liability, Current 1.24 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.84 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 3.85 M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.9 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.66 M USD
Deferred Tax Assets, Operating Loss Carryforwards 74.9 M USD +2.54%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.84 M USD
Additional Paid in Capital 1.16 B USD
Interest Expense 3.24 M USD +159%